Search
Search
About
Log in
Join
Experiences with
Adenocarcinoma
Posts
Communities
783 public posts
Filter results
Let down...again !
Considering they left me with lung
Adenocarcinoma
for 15 month's, didn't tell anybody and an Australian Radiographer had seen the tumour on my lung but our hospital forgot to say anything until I was rushed to hospital with Pneumonia.
Considering they left me with lung
Adenocarcinoma
for 15 month's, didn't tell anybody and an Australian Radiographer had seen the tumour on my lung but our hospital forgot to say anything until I was rushed to hospital with Pneumonia.
Danni54
in
The Roy Castle Lung Cancer Foundation
2 years ago
Talabostat Plus Pembrolizumab shows promise for mCRPC with Adenocarcinoma
In a phase 1b/2 study (ClinicalTrials.gov Identifier: NCT03910660), BXCL701 was evaluated in combination with pembrolizumab, a PD-1 inhibitor, in mCRPC patients with
adenocarcinoma
phenotype as well as in small-cell neuroendocrine carcinoma (SCNC).
In a phase 1b/2 study (ClinicalTrials.gov Identifier: NCT03910660), BXCL701 was evaluated in combination with pembrolizumab, a PD-1 inhibitor, in mCRPC patients with
adenocarcinoma
phenotype as well as in small-cell neuroendocrine carcinoma (SCNC).
Graham49
in
Advanced Prostate Cancer
2 years ago
PSA monitor indicated with hx of colon cancer?
Male age 46 with recent discovery of
adenocarcinoma
arising in Tubulovillous adenoma, G3 differentiation, Tumor budding score (Bd2) imtermediate, tumor extension into the submucosa (SM1 level) Pathologicaal staging at this time is p T1, NX.
Male age 46 with recent discovery of
adenocarcinoma
arising in Tubulovillous adenoma, G3 differentiation, Tumor budding score (Bd2) imtermediate, tumor extension into the submucosa (SM1 level) Pathologicaal staging at this time is p T1, NX.
MotherK
in
Colon Cancer Connected
2 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Decision time. Input welcome
The median survival for patients with metastatic castration resistant prostate
adenocarcinoma
is approximately 2 to 3 years."
The median survival for patients with metastatic castration resistant prostate
adenocarcinoma
is approximately 2 to 3 years."
Miccoman
in
Advanced Prostate Cancer
2 years ago
Dad's end of journey
He had brain metastasis due to complications of his
adenocarcinoma
turning to a neuroendocrine diferenciation. Even we tried our best, dad broke his hip so he was not eligible for receiving docetxactel either Thanks so much for all your support and your help during this journey
He had brain metastasis due to complications of his
adenocarcinoma
turning to a neuroendocrine diferenciation. Even we tried our best, dad broke his hip so he was not eligible for receiving docetxactel either Thanks so much for all your support and your help during this journey
Noel91
in
Advanced Prostate Cancer
2 years ago
Changing from Adenocarcinoma to small cells or Neuroendocrine?
Can it be
Adenocarcinoma
turn to small cells or Neuroendocrine? My dad’s bone metastasis when diagnostic of prostate cancer but only recently he feels hurt / uncomfortable at hip and / or leg. Thank you in advance for your sharing and comments.
Can it be
Adenocarcinoma
turn to small cells or Neuroendocrine? My dad’s bone metastasis when diagnostic of prostate cancer but only recently he feels hurt / uncomfortable at hip and / or leg. Thank you in advance for your sharing and comments.
Hidden
in
Advanced Prostate Cancer
2 years ago
New and scared
I’ve just been diagnosed with Metastatic
adenocarcinoma
of the lung and am starting palliative treatment of Carboplatin/Pemetrexed/Pembrolizumab therapy on Tuesday. This all has come completely out of the blue to me, and I understand very little of what I might expect.
I’ve just been diagnosed with Metastatic
adenocarcinoma
of the lung and am starting palliative treatment of Carboplatin/Pemetrexed/Pembrolizumab therapy on Tuesday. This all has come completely out of the blue to me, and I understand very little of what I might expect.
Damonaldinho
in
The Roy Castle Lung Cancer Foundation
2 years ago
New Diagnosis - feeling overwhelmed
Adenocarcinoma
- Right Lat Base <5%, Left Mid 15%, Left Lat Mid 40%, Left Apex 10%, Right Apex 50% and Right Lateral Apex 15%. All with no Perineural or lymphovascular invasion. ROI -
Adenocarcinoma
approx 80% of tissue with perineural invasion and no lymphovascular.
Adenocarcinoma
- Right Lat Base <5%, Left Mid 15%, Left Lat Mid 40%, Left Apex 10%, Right Apex 50% and Right Lateral Apex 15%. All with no Perineural or lymphovascular invasion. ROI -
Adenocarcinoma
approx 80% of tissue with perineural invasion and no lymphovascular.
ProgFish
in
Prostate Cancer Network
2 years ago
Treatment after RP with affected lymph nodes
. • 2022-April: Pathological analysis: o 1 - Prostate:
adenocarcinoma
of the prostate, Gleason index 7 (4+3), tertiary pattern minority 5 (<5%). Prognostic group 3. Bilateral affectation, both compartments, from low levels, up to glandular high levels. High tumor volume.
. • 2022-April: Pathological analysis: o 1 - Prostate:
adenocarcinoma
of the prostate, Gleason index 7 (4+3), tertiary pattern minority 5 (<5%). Prognostic group 3. Bilateral affectation, both compartments, from low levels, up to glandular high levels. High tumor volume.
Urogallo
in
Advanced Prostate Cancer
2 years ago
Ovarian Cancer clinical trial - ACTOv
I haven't had a diagnosis of Ovarian Cancer myself, but I am a twice diagnosed patient myself- Wilms tumour in 1991 and Cervical
adenocarcinoma
in 2019, so finding out about new treatments on the trials I am involved with gives me hope for future patients.
I haven't had a diagnosis of Ovarian Cancer myself, but I am a twice diagnosed patient myself- Wilms tumour in 1991 and Cervical
adenocarcinoma
in 2019, so finding out about new treatments on the trials I am involved with gives me hope for future patients.
Krobbo278
in
My Ovacome
2 years ago
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
Analysis of bone metastasis of prostatic
adenocarcinoma
in 137 autopsy cases. Adv. Exp. Med.
Analysis of bone metastasis of prostatic
adenocarcinoma
in 137 autopsy cases. Adv. Exp. Med.
Scout4answers
in
Advanced Prostate Cancer
2 years ago
More information on Lu PSMA treatment failure
I think the new growth is
adenocarcinoma
that isn't expressing PSMA. I'm not sure what this means in terms of how the treatment could have been made more effective. There seems to be anecdotal evidence that combining enzalutamide with Lu PSMA yields better benefit, but the sample size is small.
I think the new growth is
adenocarcinoma
that isn't expressing PSMA. I'm not sure what this means in terms of how the treatment could have been made more effective. There seems to be anecdotal evidence that combining enzalutamide with Lu PSMA yields better benefit, but the sample size is small.
Javelin18
in
Advanced Prostate Cancer
2 years ago
On Active Surveillance - Why not non-invasive aggressive approach?
Result confirms same as June biopsy of
Adenocarcinoma
Gleason 6, Grade 1 in about 5 cores (including 1 in ROI) at 30% and PSA holding at 2.6 for a year now. Urologist says active surveillance and to see him in 6 moonths / PSA. I'm going to get an annual physical and full blood workup.
Result confirms same as June biopsy of
Adenocarcinoma
Gleason 6, Grade 1 in about 5 cores (including 1 in ROI) at 30% and PSA holding at 2.6 for a year now. Urologist says active surveillance and to see him in 6 moonths / PSA. I'm going to get an annual physical and full blood workup.
Shagaru
in
Prostate Cancer Network
2 years ago
Lung infections after Lobectomy?
I have had the most amazing support from people on this forum particularly from Loimie and Zac and want to say thank you so much for helping me through since I was first diagnosed with
Adenocarcinoma
in my top right lung . I'm not going to go through everything again (!)
I have had the most amazing support from people on this forum particularly from Loimie and Zac and want to say thank you so much for helping me through since I was first diagnosed with
Adenocarcinoma
in my top right lung . I'm not going to go through everything again (!)
Danni54
in
The Roy Castle Lung Cancer Foundation
2 years ago
Serotonin Makes Tumors Happy Too
Serum serotonin level was found to be suitable for prognosis evaluation of urothelial carcinoma in the urinary bladder,
adenocarcinoma
of the prostate and renal cell carcinoma.
Serum serotonin level was found to be suitable for prognosis evaluation of urothelial carcinoma in the urinary bladder,
adenocarcinoma
of the prostate and renal cell carcinoma.
Hidden
in
Advanced Prostate Cancer
2 years ago
RP 2019 now rising PSA and PSMA with most likely metastatic lymph node- any comments or advice on treatment plan?
Below is pathology from RP- Prostate (Radical Prostatectomy, TS-19-05686, 2/4/2019): HISTOLOGIC TYPE
Adenocarcinoma
(conventional, NOS) GLEASON SCORE, DOMINANT NODULE 3+4=7 Grade Group 2 40% Pattern 4 (tertiary pattern 5) TUMOR EXTENT Tumor dimension (max): 24.0 mm LOCATION, DOMINANT NODULE
Below is pathology from RP- Prostate (Radical Prostatectomy, TS-19-05686, 2/4/2019): HISTOLOGIC TYPE
Adenocarcinoma
(conventional, NOS) GLEASON SCORE, DOMINANT NODULE 3+4=7 Grade Group 2 40% Pattern 4 (tertiary pattern 5) TUMOR EXTENT Tumor dimension (max): 24.0 mm LOCATION, DOMINANT NODULE
WickedNeptune
in
Prostate Cancer Network
2 years ago
GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity
Serum serotonin level was found to be suitable for prognosis evaluation of urothelial carcinoma in the urinary bladder,
adenocarcinoma
of the prostate and renal cell carcinoma.
Serum serotonin level was found to be suitable for prognosis evaluation of urothelial carcinoma in the urinary bladder,
adenocarcinoma
of the prostate and renal cell carcinoma.
Hidden
in
Advanced Prostate Cancer
2 years ago
Extracts from two papers on exercise and cancer. Paper 1 investigates the blood from 25 patients with mCRPC exercising. Paper 2 is a review.
Briefly, patients who had been identified as mCRPC (
adenocarcinoma
of the prostate with systemic metastatic disease despite castrate levels of testosterone (<50 ng/dl) due to orchiectomy or luteinising hormone-releasing hormone (LHRH) agonist, undergoing ADT (gonadotropin-releasing hormone (GnRH) agonist
Briefly, patients who had been identified as mCRPC (
adenocarcinoma
of the prostate with systemic metastatic disease despite castrate levels of testosterone (<50 ng/dl) due to orchiectomy or luteinising hormone-releasing hormone (LHRH) agonist, undergoing ADT (gonadotropin-releasing hormone (GnRH) agonist
Graham49
in
Advanced Prostate Cancer
2 years ago
PSA following ADT and RT
He was diagnosed with a gleason 8
adenocarcinoma
with local spread to the lymph nodes, EPE+, right SVI+, psa 308.
He was diagnosed with a gleason 8
adenocarcinoma
with local spread to the lymph nodes, EPE+, right SVI+, psa 308.
Pcsurvival89
in
Advanced Prostate Cancer
2 years ago
CoQ10 Good or Bad? Necessary? Reaching a Conclusion, Coenzyme Q10, Statins, Prostate Cancer
., In vivo metabolic tracing to demonstrate that pancreatic ductal
adenocarcinoma
(PDAC) tumors rely on the mevalonate pathway to synthesize CoQ de novo.
., In vivo metabolic tracing to demonstrate that pancreatic ductal
adenocarcinoma
(PDAC) tumors rely on the mevalonate pathway to synthesize CoQ de novo.
jazj
in
Advanced Prostate Cancer
2 years ago
1
...
9
10
11
...
40
Next page
10
20
30
40
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
300 results
The Roy Castle Lung Cancer Foundation
140 results
Lung Cancer Support
100 results
View top 10 communities
Sort by
Most Relevant
Newest